Decreased FOXO3 transcriptional activity and nuclear localization following TP agonist treatment. by Philip M. Sobolesky (627538)

“…<p>(<b>A</b>) UMUC3 cells transiently transfected with 3× forkhead response element (FHRE) reporter construct and Renilla luciferase control vector were treated with 1 µM U46619 for 30 or 120 minutes and resulted in decreased FOXO3 transcriptional activity. …”

Procedure for study 1. by Duyan Geng (12072181)

miR-142-5p as a blood biomarker of CAMR by Richard Danger (221235)

“…<p>A) TLDA and individual qPCR measurements performed in same PBMC samples (10 STA and 9 CAMR) are displayed for miR-142-5p. …”

A representative dataset of multiphase ALADDIN with different gap sizes (300% and 450% of slice thickness) and different inter-slice delay time (TD) (0 and 500 ms) from one represe... by Ki Hwan Kim (427869)

Proposed concept of collaterals action: The collateral circulation lowered the pressure across the clot which resulted in lesser clot compaction and a subsequent easier clot distal... by Sandra Thalerová (11434762)

Effect of single dose cranial irradiation on circulating endothelial progenitor cell number. by Nikolett Sándor (659792)

The mean movement and disability scales in the patients with <i>DYT</i>-1 dystonia, PKAN, and tardive dystonia. by Hye Ran Park (844306)

The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level. by Kaitao Zhao (3617825)

mPEG PV1-Fab’ treatment decreases T_reg population. by Pedro Henrique Papotto (791904)

table3_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

“…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”

table1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

“…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”

image2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

“…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”

table2_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

“…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”

image1_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.jpeg by Jordi Rodon (201558)

“…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”

table4_Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen.pdf by Jordi Rodon (201558)

“…Here, we have screened existing drugs approved for human use in a variety of diseases, to compare how they counteract SARS-CoV-2-induced cytopathic effect and viral replication in vitro. …”

Additional file 1 of Second ejaculation produces good quality sperm and blastocyst and decreases the rate of unexpected ICSI cycle: a propensity score-matched analysis by Xiaohui Zhang (81778)

Total enteral sIgA (A) and rTsCTL specific sIgA (B) in enteric washing fluid of vaccinated mice. by Bo Ning Wang (16965117)

Supplementary Figure 3 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

Supplementary Figure 2 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)

Supplementary Figure 1 from Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression by Thomas J. Rogers (8041841)